Article
PRA Acquisition of Pharma Bio-Research May Lead to New Drug Development Labs in US
Author(s):
PRA International (Reston, VA, www.prainternational.com) has completed the acquisition of Pharma Bio-Research (Zuidlaren, The Netherlands), an early-phase clinical development and bioanalytical company.
PRA International (Reston, VA, www.prainternational.com) has completed the acquisition of Pharma Bio-Research (Zuidlaren, The Netherlands), an early-phase clinical development and bioanalytical company. Plans for PRA International to acquire Pharma Bio-Research were originally announced on June 19. The acquisition, valued at 84.6 million Euros, provides PRA International with early-phase development and bioanalytical laboratory facilities in Europe. PRA also expects to draw on Pharma Bio-Research’s expertise to establish drug development laboratory facilities in the US for biotech and pharmaceutical clients.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
